4.7 Article

Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Medicine, General & Internal

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer

L. Gandhi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Biotechnology & Applied Microbiology

nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors

Hatem H. Soliman

ONCOTARGETS AND THERAPY (2017)

Article Gastroenterology & Hepatology

Hypermutation In Pancreatic Cancer

Jeremy L. Humphris et al.

GASTROENTEROLOGY (2017)

Review Oncology

Combination cancer immunotherapies tailored to the tumour microenvironment

Mark J. Smyth et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Immunology

Inflammatory networks and immune surveillance of pancreatic carcinoma

Robert H. Vonderheide et al.

CURRENT OPINION IN IMMUNOLOGY (2013)

Article Multidisciplinary Sciences

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov et al.

NATURE (2013)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Dermatology

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

Alice P. Chen et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)

Review Biotechnology & Applied Microbiology

The secret ally: immunostimulation by anticancer drugs

Lorenzo Galluzzi et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Article Oncology

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

JMD Plate et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)

Article Public, Environmental & Occupational Health

Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: The TREND statement

DC Des Jarlais et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2004)